CYP2C9 and oral anticoagulation therapy with acenocoumarol and warfarin: similarities yet differences

Clin Pharmacol Ther. 2004 May;75(5):376-80. doi: 10.1016/j.clpt.2004.01.007.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Acenocoumarol / administration & dosage
  • Acenocoumarol / pharmacokinetics*
  • Administration, Oral
  • Anticoagulants / administration & dosage
  • Anticoagulants / pharmacokinetics*
  • Aryl Hydrocarbon Hydroxylases / genetics*
  • Cytochrome P-450 CYP2C9
  • Humans
  • Pharmacogenetics
  • Polymorphism, Genetic
  • Warfarin / administration & dosage
  • Warfarin / pharmacokinetics*

Substances

  • Anticoagulants
  • Warfarin
  • CYP2C9 protein, human
  • Cytochrome P-450 CYP2C9
  • Aryl Hydrocarbon Hydroxylases
  • Acenocoumarol